Ernest Asante-Appiah
5PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jun 12, 2024
No antagonism or cross-resistance and a high barrier to the emergence of resistance in vitro for the combination of islatravir and lenacapavir.Tracy L Diamond, Shih Lin Goh, Winnie Ngo
|May 12, 2022
Islatravir Has a High Barrier to Resistance and Exhibits a Differentiated Resistance Profile from Approved Nucleoside Reverse Transcriptase Inhibitors (NRTIs).Tracy L Diamond, Winnie Ngo, Min Xu
|May 02, 2022
Doravirine and Islatravir Have Complementary Resistance Profiles and Create a Combination with a High Barrier to Resistance.Ming-Tain Lai, Meizhen Feng, Min Xu
|Sep 27, 2021
Impact of HIV-1 Resistance-Associated Mutations on Susceptibility to Doravirine: Analysis of Real-World Clinical Isolates.Ernest Asante-Appiah, Johnny Lai, Hong Wan
|Sep 19, 2019
Interplay of Amino Acid Residues at Positions 28 and 31 in NS5A Defines Resistance Pathways in HCV GT2.Ernest Asante-Appiah, Paul Ingravallo, Patricia McMonagle
Pageof 1
